A bone marrow transplant, or stem cell transplant, places blood stem cells back into the body. The transplant replaces cells that cancer or treatments have destroyed. People may have a bone marrow ...

Autologous stem cell transplantation (ASCT) is an established consolidation therapy for patients with relapsed or refractory lymphoma. In this procedure, high-dose chemotherapy is administered to ...

Blood cancers such as leukemia, lymphoma, and myeloma often begin in the bone marrow and disrupt normal blood cell formation.

CAR2119’s single-infusion approach offers cost and compliance advantages, though its competitors maintain strong commercial ...

Every year, more than 80,000 Americans hear these life-changing words: You have non-Hodgkin’s lymphoma, a blood cancer.

For the first time ever, a patient has received an allogeneic stem cell transplant using a deceased donor graft as part of a blood cancer clinical trial at Huntsman Cancer Institute at the University ...

Has come back (relapsed) within a year of treatment or does not go away (refractory) after your first treatment Has relapsed or is refractory and you cannot receive a hematopoietic stem cell ...

For nearly three decades, Carl Arredondo was a familiar face in New Orleans. He was a steady voice forecasting everything ...

Allogeneic HSCT achieved 92% sustained, medication-free remission and 100% survival in children with monogenic IBD, highlighting its potential as a transformative treatment. Monogenic IBD, ...